|
⚲
|
| Keyboard |
| Goldman Jonathan
✚
|
|
|---|---|
| CIK # | 0002013869 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002013869] | |
| 4 | [0002013869] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Goldman Jonathan | |
| Avalo Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2026-03-28 | Option exercise | 3,166 | ||
|
Avalo Therapeutics Inc AVTX
Restricted Stock Units · derivative
|
2026-03-28 | Option exercise | 3,166 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2025-11-14 | Sell | 8,200 | $14.35 | 117,670 |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2025-11-14 | Option exercise | 8,200 | $9.88 | 81,016 |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2025-11-14 | Sell | 3,167 | $14.30 | 45,288 |
|
Avalo Therapeutics Inc AVTX
Stock Option (Right to Buy) · derivative
|
2025-11-14 | Option exercise | 8,200 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Stock Option (Right to Buy) · derivative
|
2025-06-17 | Grant | 20,100 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2025-03-28 | Option exercise | 3,167 | ||
|
Avalo Therapeutics Inc AVTX
Restricted Stock Units · derivative
|
2025-03-28 | Option exercise | 3,167 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Restricted Stock Units · derivative
|
2024-08-13 | Grant | 9,500 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Stock Option (Right to Buy) · derivative
|
2024-08-13 | Grant | 24,600 | $0.00 |